FLAM
KRTX

First Light Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

First Light Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-287,037
Closed -$90.9M – 86
2023
Q4 		$90.9M Sell
287,037
-16,100
-5% -$3.13M 7.31% 1
2023
Q3 		$51.3M Buy
303,137
+94,391
+45% +$17.7M 4.87% 4
2023
Q2 		$45.3M Sell
208,746
-34,929
-14% -$7.48M 3.55% 7
2023
Q1 		$44.3M Buy
243,675
+79,060
+48% +$15.1M 3.99% 8
2022
Q4 		$32.3M Sell
164,615
-1,701
-1% -$365K 3% 9
2022
Q3 		$37.4M Buy
166,316
+40,523
+32% +$8.2M 3.79% 5
2022
Q2 		$15.9M Buy
125,793
+8,924
+8% +$1.03M 1.85% 22
2022
Q1 		$14.8M Sell
116,869
-164,832
-59% -$18.6M 1.31% 26
2021
Q4 		$36.9M Buy
281,701
+6,057
+2% +$783K 2.64% 12
2021
Q3 		$33.7M Buy
275,644
+864
+0.3% +$99.7K 2.22% 19
2021
Q2 		$31.3M Buy
274,780
+16,280
+6% +$1.9M 1.88% 23
2021
Q1 		$31.1M Buy
258,500
+121,100
+88% +$13.7M 2.06% 21
2020
Q4 		$14M Buy
137,400
+9,200
+7% +$852K 1.03% 29
2020
Q3 		$9.91M Buy
+128,200
New +$10.9M 1.02% 29

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

First Light Asset Management's KRTX Position: Q1 2024 in Review

First Light Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 287,037 shares — an estimated $90.9M sold.

First Light Asset Management first reported a position in KRTX in Q3 2020 and held it in 14 quarters. The position peaked at $90.9M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • First Light Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • First Light Asset Management sold 287,037 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $90.9M.
  • First Light Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • First Light Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $90.9M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on First Light Asset Management's 13F filing for Q1 2024, filed 15 May 2024.